IMCHECK THERAPEUTICS
HQ - Marseille
Summary
ImCheck Therapeutics, a private French biotech company developing immuno-oncology therapies targeting butyrophilins and γδ T-cell biology.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 960 M
Avg. Deal Size£ 480 M
All rights reserved. Copyright © 2025 Datasite
